A Study of LY900014 in Healthy Chinese Participants
Status:
Completed
Trial end date:
2020-09-29
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate a new formulation of insulin lispro, LY900014, which
is a drug that lowers blood sugar. The study will look at how the body processes LY900014 and
the affect of LY900014 on blood sugar levels. For each participant, the study will consist of
3 periods and will last about 51 days.